ALLO logo

Allogene Therapeutics (ALLO) EV/EBITDA

EV/EBITDA

-2.14
+0.06+2.73%

Thu, 28 Nov 2024 00:53:03 GMT

ALLO EV/EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALLO EV/EBITDA Performance

PeriodPeriodEV/EBITDAEV/EBITDA
todaytoday+2.7%
1 m1 month+0.5%
3 m3 months-15.1%
6 m6 months-2.9%
ytdytd-15.1%
1 y1 year-54.0%
5 y5 years+89.3%

ALLO EV/EBITDA High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month-1.78-20.2%-2.74+21.9%
3 m3 months-1.64-30.5%-2.74+21.9%
6 m6 months-1.40-52.9%-2.74+21.9%
1 y1 year-1.30-64.6%-3.20+33.1%
3 y3 years-1.30-64.6%-12.26+82.5%
5 y5 years-1.30-64.6%-30.84+93.1%
alltimeall time-1.30-64.6%-30.84+93.1%

Allogene Therapeutics EV/EBITDA History

DateValue
2024
-2.14(+15.1%)
2023
-1.86(-37.2%)
2022
-2.96(-75.2%)
DateValue
2021
-11.95(-12.3%)
2020
-13.62(-13.6%)
2019
-15.77(+1.5%)
2018
-15.53

FAQ

  • What is Allogene Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Allogene Therapeutics?
  • What is ALLO EV/EBITDA year-to-date change?
  • What is Allogene Therapeutics EV/EBITDA year-on-year change?

What is Allogene Therapeutics EV/EBITDA?

The current EV/EBITDA of ALLO is -2.14

What is the all time high EV/EBITDA for Allogene Therapeutics?

Allogene Therapeutics all-time high EV/EBITDA is -1.30

What is ALLO EV/EBITDA year-to-date change?

Allogene Therapeutics EV/EBITDA has changed by -0.28 (-15.05%) since the beginning of the year

What is Allogene Therapeutics EV/EBITDA year-on-year change?

Over the past year, ALLO EV/EBITDA has changed by -0.75 (-53.96%)